
RETATRUTIDE 5 MG KIT -5 MG / VIAL -3 VIALS
RETATRUTIDE – 5 MG KIT (5 MG / VIAL × 3VIALS) –
🧪 Product Type
Peptide / Triple Hormonal Receptor Agonist
Active Ingredient: Retatrutide
Dosage Form: Lyophilized powder for reconstitution
Packaging: 3 vials per kit
📄 Description
cutting-edge investigational peptide designed to activate three key hormonal receptors:
GLP-1 (Glucagon-Like Peptide-1)
GIP (Gastric Inhibitory Polypeptide)
Glucagon Receptor
This triple-agonist peptide has demonstrated promising effects in early research studies for its ability to support weight management, enhance insulin sensitivity, and improve metabolic performance. It is intended strictly for laboratory research and non-human use.
🔹 Product Features
Concentration: 5 MG Retatrutide per vial
Form: Lyophilized peptide (requires reconstitution with bacteriostatic water)
Storage: Keep refrigerated at 2°C–8°C after reconstitution
Purity: High-purity pharmaceutical-grade research peptide
✅ Key Research Benefits
🧬 Multi-Receptor Activation
Simultaneously targets GLP-1, GIP & glucagon receptors for synergistic metabolic impact
🔥 Weight Reduction Support
Helps reduce food intake and increase fat oxidation
💉 Glucose & Insulin Modulation
Promotes improved glycemic control and insulin function
⚖️ Energy Balance
May contribute to increased energy expenditure and metabolic flexibility
📈 Suggested Research Use (For Laboratory Purposes Only)
Retatrutide should be reconstituted with bacteriostatic water prior to subcutaneous administration.
Dosage protocols vary based on study design, species model, and target endpoints.
⚠️ Possible Side Effects (Observed in Research)
Transient nausea
GI discomfort
Appetite suppression
Injection site redness or swelling
All effects appear to be dose-dependent and should be monitored throughout the study.
🚫 Contraindications (For Research Planning)
Retatrutide is not recommended in research models with:
A history of medullary thyroid carcinoma
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Known hypersensitivity to peptide compounds
🛒 Purchase & Availability
For Research Use Only – Not for Human Consumption
Format: 5 MG KIT (3 vials × 2 MG)
Available through certified research suppliers
Estimated Shipping: 5–12 business days, depending on region
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
RETATRUTIDE – 5 MG KIT (5 MG / VIAL × 3VIALS) –
🧪 Product Type
Peptide / Triple Hormonal Receptor Agonist
Active Ingredient: Retatrutide
Dosage Form: Lyophilized powder for reconstitution
Packaging: 3 vials per kit
📄 Description
cutting-edge investigational peptide designed to activate three key hormonal receptors:
GLP-1 (Glucagon-Like Peptide-1)
GIP (Gastric Inhibitory Polypeptide)
Glucagon Receptor
This triple-agonist peptide has demonstrated promising effects in early research studies for its ability to support weight management, enhance insulin sensitivity, and improve metabolic performance. It is intended strictly for laboratory research and non-human use.
🔹 Product Features
Concentration: 5 MG Retatrutide per vial
Form: Lyophilized peptide (requires reconstitution with bacteriostatic water)
Storage: Keep refrigerated at 2°C–8°C after reconstitution
Purity: High-purity pharmaceutical-grade research peptide
✅ Key Research Benefits
🧬 Multi-Receptor Activation
Simultaneously targets GLP-1, GIP & glucagon receptors for synergistic metabolic impact
🔥 Weight Reduction Support
Helps reduce food intake and increase fat oxidation
💉 Glucose & Insulin Modulation
Promotes improved glycemic control and insulin function
⚖️ Energy Balance
May contribute to increased energy expenditure and metabolic flexibility
📈 Suggested Research Use (For Laboratory Purposes Only)
Retatrutide should be reconstituted with bacteriostatic water prior to subcutaneous administration.
Dosage protocols vary based on study design, species model, and target endpoints.
⚠️ Possible Side Effects (Observed in Research)
Transient nausea
GI discomfort
Appetite suppression
Injection site redness or swelling
All effects appear to be dose-dependent and should be monitored throughout the study.
🚫 Contraindications (For Research Planning)
Retatrutide is not recommended in research models with:
A history of medullary thyroid carcinoma
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Known hypersensitivity to peptide compounds
🛒 Purchase & Availability
For Research Use Only – Not for Human Consumption
Format: 5 MG KIT (3 vials × 2 MG)
Available through certified research suppliers
Estimated Shipping: 5–12 business days, depending on region












